Therapy Areas: Inflammatory Diseases
22 October 2025 - Healthcare company Trellus Health plc (AIM: TRLS) announced on Wednesday that it has signed a 12-month contract with one of the world's largest Clinical Research Organisations (...
21 October 2025 - The Lupus Foundation of America Inc reported on Monday that the US Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab), developed by biotechnology company Genentech...
20 October 2025 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) announced on Monday that it has received US Food and Drug Administration (FDA) approval for Tezspire (te...
20 October 2025 - CStone Pharmaceuticals (HKEX:2616), a China-based biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...
9 October 2025 - US medical device company Autonomix Medical, Inc. (NASDAQ: AMIX) announced on Thursday that it has been granted a patent from the United States Patent and Trademark Office covering sy...
8 October 2025 - Precision diagnostic tests provider Oxford BioDynamics plc (AIM: OBD) on Wednesday announced the development of a first-in-class blood test for diagnosing Chronic Fatigue Syndrome (CF...